News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lamond David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Lamond David (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 107,886 shares
@ $1.32, valued at
$142.4k
Bought 117,348 shares
@ $1.29, valued at
$151.4k
Bought 24,766 shares
@ $1.29, valued at
$31.9k
|
|
| 05/26/2023 |
4
| Lamond David (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Lamond David (Director) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Granted 59,459 options to buy
@ $1.85, valued at
$110k
|
|
| 05/26/2022 |
4
| Lamond David (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.13, valued at
$62.6k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Lamond David (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Bought 33,000 shares
@ $3.08, valued at
$101.6k
Bought 33,500 shares
@ $3.26, valued at
$109.2k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Lamond David (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 15,175 options to buy
@ $47.01, valued at
$713.4k
|
|
| 04/07/2021 |
4
| Lamond David (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Bought 25,000 shares
@ $42, valued at
$1.1M
|
|
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Lamond David (Director) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Converted 53,629 shares
@ $0
Converted 92,756 shares
@ $0
Converted 53,629 preferred shares
@ $0
Converted 92,756 preferred shares
@ $0 |
|
| 02/04/2021 |
3
| Lamond David (Director) has filed a Form 3 on Lucira Health, Inc. |
| 06/11/2020 |
4
| Lamond David (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Converted 914,589 shares
@ $0
Granted 71,430 shares
@ $14, valued at
$1M
Converted 1 preferred shares
@ $0 |
|
| 06/09/2020 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 11,029 options to buy
@ $41.73, valued at
$460.2k
|
|
| 06/08/2020 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 13,609 shares
@ $42.1322, valued at
$573.4k
Bought 10,642 shares
@ $43.3221, valued at
$461k
Bought 24,874 shares
@ $43.8765, valued at
$1.1M
|
|
| 06/04/2020 |
3
| Lamond David (Director) has filed a Form 3 on Applied Molecular Transport Inc. |
| 05/19/2020 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 1,263 shares
@ $46.3007, valued at
$58.5k
Bought 985 shares
@ $48.365, valued at
$47.6k
Bought 1,600 shares
@ $48.9584, valued at
$78.3k
Bought 1,000 shares
@ $50.7073, valued at
$50.7k
Bought 500 shares
@ $52.201, valued at
$26.1k
Bought 100 shares
@ $53.1, valued at
$5.3k
Bought 400 shares
@ $54.09, valued at
$21.6k
Bought 5,906 shares
@ $55.4197, valued at
$327.3k
Bought 32,894 shares
@ $56.4157, valued at
$1.9M
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2019 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Converted 1,623,336 shares
@ $0
Converted 301,829 shares
@ $0
Converted 699,280 options to buy
@ $0
Converted 301,829 options to buy
@ $0
Converted 924,056 options to buy
@ $0 |
|
| 05/08/2019 |
3
| Lamond David (Director) has filed a Form 3 on Cortexyme, Inc. |
|
|